Medifast Inc Stock Current Liabilities
| MED Stock | USD 32.47 0.59 1.85% |
MEDIFAST INC fundamentals help investors to digest information that contributes to MEDIFAST INC's financial success or failures. It also enables traders to predict the movement of MEDIFAST Stock. The fundamental analysis module provides a way to measure MEDIFAST INC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MEDIFAST INC stock.
At present, MEDIFAST INC's Non Current Liabilities Total is projected to increase significantly based on the last few years of reporting. MEDIFAST | Current Liabilities |
MEDIFAST INC Company Current Liabilities Analysis
MEDIFAST INC's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current MEDIFAST INC Current Liabilities | 23.56 M |
Most of MEDIFAST INC's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MEDIFAST INC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MEDIFAST Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for MEDIFAST INC is extremely important. It helps to project a fair market value of MEDIFAST Stock properly, considering its historical fundamentals such as Current Liabilities. Since MEDIFAST INC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MEDIFAST INC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MEDIFAST INC's interrelated accounts and indicators.
Click cells to compare fundamentals
MEDIFAST Current Liabilities Historical Pattern
Today, most investors in MEDIFAST INC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MEDIFAST INC's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of MEDIFAST INC current liabilities as a starting point in their analysis.
MEDIFAST INC Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
MEDIFAST Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, MEDIFAST INC has a Current Liabilities of 23.56 M. This is 99.95% lower than that of the Personal Care Products sector and 96.01% lower than that of the Consumer Staples industry. The current liabilities for all United States stocks is 99.7% higher than that of the company.
MEDIFAST Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MEDIFAST INC's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MEDIFAST INC could also be used in its relative valuation, which is a method of valuing MEDIFAST INC by comparing valuation metrics of similar companies.MEDIFAST INC is currently under evaluation in current liabilities category among related companies.
MEDIFAST Fundamentals
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.25 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 209.97 M | ||||
| Shares Outstanding | 10.9 M | ||||
| Shares Owned By Insiders | 2.70 % | ||||
| Shares Owned By Institutions | 97.40 % | ||||
| Number Of Shares Shorted | 2.66 M | ||||
| Price To Earning | 13.99 X | ||||
| Price To Book | 1.70 X | ||||
| Price To Sales | 0.32 X | ||||
| Revenue | 1.07 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 139.51 M | ||||
| Net Income | 99.42 M | ||||
| Cash And Equivalents | 87.69 M | ||||
| Cash Per Share | 5.57 X | ||||
| Total Debt | 22.01 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 18.69 X | ||||
| Cash Flow From Operations | 147.66 M | ||||
| Short Ratio | 5.83 X | ||||
| Earnings Per Share | 9.10 X | ||||
| Price To Earnings To Growth | 1.95 X | ||||
| Target Price | 37.5 | ||||
| Number Of Employees | 634 | ||||
| Beta | 1.15 | ||||
| Market Capitalization | 351.38 M | ||||
| Total Asset | 309.91 M | ||||
| Retained Earnings | 174.65 M | ||||
| Working Capital | 131.73 M | ||||
| Current Asset | 88.07 M | ||||
| Current Liabilities | 23.56 M | ||||
| Annual Yield | 0.20 % | ||||
| Five Year Return | 2.53 % | ||||
| Net Asset | 309.91 M | ||||
| Last Dividend Paid | 4.95 |
About MEDIFAST INC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEDIFAST INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEDIFAST INC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEDIFAST INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out MEDIFAST INC Piotroski F Score and MEDIFAST INC Altman Z Score analysis. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.